概括
这篇社论强调了一个囊性纤维化患者的病例研究,该患者患有慢性鼻炎和鼻. 该研究详细介绍了在CFTR调节疗法后发现NSAID加重的呼吸道疾病.
科学领域:
- 鼻科和过敏科 鼻科和过敏科
- 肺部病理学 肺部病理学
- 医学案例研究 医学案例研究
背景情况:
- 囊性纤维化 (CF) 通常与慢性鼻炎 (CRS) 和鼻息肉共存.
- 无抗药加剧性呼吸道疾病 (NERD) 是一个独特的临床实体,属于呼吸道炎症疾病的范围.
- CFTR调制疗法代表了CF治疗的重大进步.
研究的目的:
- 报告在患有囊性纤维化 (CF) 和患有鼻多的慢性鼻炎 (CRS) 的患者中发现的同时出现NSAID加重的呼吸道疾病 (NERD) 的病例.
- 描述三重组合CFTR调节疗法 (ETI) 开始后的临床过程和管理.
主要方法:
- 病例报告详细说明了临床表现,诊断工作和治疗干预措施.
- 检查病史,包括先前的诊断和对药物的反应.
主要成果:
- 该患者被诊断为CF和CRS与鼻,在开始ETI治疗后出现了暗示NERD的症状.
- 尽管启动了CFTR调节治疗,NERD症状的出现仍然发生,这表明疾病的复杂相互作用.
结论:
- 开始ETI治疗可能会揭露或与CF和CRS敏感个体的NERD的发展有关.
- 这一案例强调了在CF和CRS患者中考虑和评估NERD的重要性,特别是在启动新疗法时.
相关概念视频
Cystic Fibrosis: Management
225
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
225
Cystic Fibrosis: Pathogenesis
368
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
368
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Asthma: Pathogenesis and Management
599
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
599
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Drugs Used in Lower Respiratory Disorders: Overview
595
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
595


